Oncosil Medical Ltd
ASX:OSL
EV/IC
Enterprise Value to IC
Enterprise Value to Invested Capital (EV/IC) ratio is a valuation multiple that measures the dollars in Enterprise Value for each dollar of capital invested by shareholders and lenders.
Market Cap | EV/IC | ||||
---|---|---|---|---|---|
AU |
Oncosil Medical Ltd
ASX:OSL
|
14.8m AUD | -28.5 | ||
US |
Thermo Fisher Scientific Inc
NYSE:TMO
|
231.8B USD | 2.9 | ||
US |
Danaher Corp
NYSE:DHR
|
194.7B USD | 2.7 | ||
US |
Agilent Technologies Inc
NYSE:A
|
45.1B USD | 5.2 | ||
US |
IQVIA Holdings Inc
NYSE:IQV
|
42.5B USD | 2.5 | ||
KR |
Samsung Biologics Co Ltd
KRX:207940
|
55.6T KRW | 3.9 | ||
CH |
Lonza Group AG
SIX:LONN
|
38.3B CHF | 2.7 | ||
US |
Mettler-Toledo International Inc
NYSE:MTD
|
32.3B USD | 11.3 | ||
IE |
ICON PLC
NASDAQ:ICLR
|
26.5B USD | 1.8 | ||
US |
West Pharmaceutical Services Inc
NYSE:WST
|
25.6B USD | 9.1 | ||
US |
Waters Corp
NYSE:WAT
|
21.3B USD | 5.7 |
EV/IC Forward Multiples
Forward EV/IC multiple is a version of the EV/IC ratio that uses forecasted invested capital for the EV/IC calculation. 1-Year, 2-Years, and 3-Years forwards use invested capital forecasts for 1, 2, and 3 years ahead, respectively.